$14.65
0.47[3.31%]
At close: Apr 26
$14.65
0[0.00%]
After Hours: 4:20PM EDT
Deciphera Pharmaceuticals
(NASDAQ:DCPH)Deciphera Pharmaceuticals Stock (NASDAQ:DCPH), Insider Trading Activity
Deciphera Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
82.226M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 14.66K | $15.62 | -$40.84K | GRANT | 15.58% | 108.739K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 14.265K | $15.62 | -$47.01K | GRANT | 21.59% | 80.35K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Jama Pitman | SVP, CHIEF DEVELOPMENT OFFICER | 17.458K | $15.62 | -$35.41K | GRANT | 34.52% | 68.031K | Feb 15 - Feb 16 | View |
| Feb 20, 2024 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 7.458K | $15.62 | -$35.41K | GRANT | 15.65% | 55.118K | Feb 15 - Feb 16 | View |
| Jan 18, 2024 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | -2.435K | $14.47 | -$35.23K | SELL | -2.52% | 94.079K | Jan 16 | View |
| Jan 18, 2024 | Jama Pitman | SVP, CHIEF DEVELOPMENT OFFICER | -1.624K | $14.47 | -$23.50K | SELL | -3.11% | 50.573K | Jan 16 | View |
| Jan 18, 2024 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | -2.435K | $14.47 | -$35.23K | SELL | -3.55% | 66.085K | Jan 16 | View |
| Jan 18, 2024 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -1.624K | $14.47 | -$23.50K | SELL | -3.30% | 47.66K | Jan 16 | View |
| Dec 14, 2023 | Steven Hoerter | PRESIDENT AND CEO | 31.836K | $15.37 | -$471.22K | GRANT | 77.79% | 72.763K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 5.452K | $15.37 | -$42.90K | GRANT | 8.64% | 68.52K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Jama Pitman | SEE REMARKS | 3.914K | $15.37 | -$25.54K | GRANT | 8.11% | 52.197K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 3.849K | $15.37 | -$26.54K | GRANT | 8.47% | 49.284K | Dec 12 - Dec 13 | View |
| Dec 14, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 5.452K | $15.37 | -$42.90K | GRANT | 5.99% | 96.514K | Dec 12 - Dec 13 | View |
| Dec 01, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | -17.801K | $12.57 | -$223.76K | SELL | -28.15% | 45.435K | Nov 30 | View |
| Oct 31, 2023 | Matthew Sherman | EVP & CHIEF MEDICAL OFFICER | 5.884K | $12.02 | -$28.36K | GRANT | 6.94% | 90.628K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Jama Pitman | SEE REMARKS | 4.169K | $12.02 | -$16.91K | GRANT | 9.45% | 48.283K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Daniel Martin | CHIEF COMMERCIAL OFFICER | 4.169K | $12.02 | -$16.91K | GRANT | 7.10% | 62.884K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Patrick Thomas Kelly | CHIEF FINANCIAL OFFICER | 5.928K | $12.02 | -$27.83K | GRANT | 10.37% | 63.068K | Oct 28 - Oct 30 | View |
| Oct 31, 2023 | Steven Hoerter | PRESIDENT AND CEO | 40.927K | $12.02 | -$259.26K | GRANT | ∞ | 40.927K | Oct 28 - Oct 30 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.